These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 10573519)

  • 21. Hepatocyte growth factor-induced proliferation of hepatic stem-like cells depends on activation of NF-kappaB.
    Yao P; Zhan Y; Xu W; Li C; Yue P; Xu C; Hu D; Qu CK; Yang X
    J Hepatol; 2004 Mar; 40(3):391-8. PubMed ID: 15123351
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analysis of liver regeneration in mice lacking type 1 or type 2 tumor necrosis factor receptor: requirement for type 1 but not type 2 receptor.
    Yamada Y; Webber EM; Kirillova I; Peschon JJ; Fausto N
    Hepatology; 1998 Oct; 28(4):959-70. PubMed ID: 9755232
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lipopolysaccharide potentiates the effect of hepatocyte growth factor upon replication in lung, thyroid, spleen, and colon in rats in vivo.
    Gao C; Kennedy S; Ponder KP
    Mol Ther; 2001 Apr; 3(4):462-75. PubMed ID: 11319906
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epigallocatechin-3-gallate selectively inhibits interleukin-1beta-induced activation of mitogen activated protein kinase subgroup c-Jun N-terminal kinase in human osteoarthritis chondrocytes.
    Singh R; Ahmed S; Malemud CJ; Goldberg VM; Haqqi TM
    J Orthop Res; 2003 Jan; 21(1):102-9. PubMed ID: 12507586
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hepatocyte growth factor/scatter factor activates proliferation in melanoma cells through p38 MAPK, ATF-2 and cyclin D1.
    Recio JA; Merlino G
    Oncogene; 2002 Feb; 21(7):1000-8. PubMed ID: 11850817
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mutant human tumor suppressor p53 modulates the activation of mitogen-activated protein kinase and nuclear factor-kappaB, but not c-Jun N-terminal kinase and activated protein-1.
    Gulati AP; Yang YM; Harter D; Mukhopadhyay A; Aggarwal BB; Benzil DL; Whysner J; Albino AP; Murali R; Jhanwar-Uniyal M
    Mol Carcinog; 2006 Jan; 45(1):26-37. PubMed ID: 16267831
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A peptide fragment of ependymin neurotrophic factor uses protein kinase C and the mitogen-activated protein kinase pathway to activate c-Jun N-terminal kinase and a functional AP-1 containing c-Jun and c-Fos proteins in mouse NB2a cells.
    Adams DS; Hasson B; Boyer-Boiteau A; El-Khishin A; Shashoua VE
    J Neurosci Res; 2003 May; 72(3):405-16. PubMed ID: 12692907
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Studies on cell signaling immunomodulated murine peritoneal suppressor macrophages: LPS and PMA mediate the activation of RAF-1, MAPK p44 and MAPK p42 and p38 MAPK].
    Chang ZL; Lin MQ; Wang MZ; Yao Z
    Shi Yan Sheng Wu Xue Bao; 1997 Mar; 30(1):73-81. PubMed ID: 10684111
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential activation of c-Jun NH2-terminal kinase and p38 mitogen-activated protein kinases by methyl methanesulfonate in the liver and brain of rats: implication for organ-specific carcinogenesis.
    Suh Y; Kang UG; Kim YS; Kim WH; Park SC; Park JB
    Cancer Res; 2000 Sep; 60(18):5067-73. PubMed ID: 11016630
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Additive and inhibitory effects of simultaneous treatment with growth factors on DNA synthesis through MAPK pathway and G1 cyclins in rat hepatocytes.
    Moriuchi A; Hirono S; Ido A; Ochiai T; Nakama T; Uto H; Hori T; Hayashi K; Tsubouchi H
    Biochem Biophys Res Commun; 2001 Jan; 280(1):368-73. PubMed ID: 11162525
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quercetin glucuronide prevents VSMC hypertrophy by angiotensin II via the inhibition of JNK and AP-1 signaling pathway.
    Yoshizumi M; Tsuchiya K; Suzaki Y; Kirima K; Kyaw M; Moon JH; Terao J; Tamaki T
    Biochem Biophys Res Commun; 2002 May; 293(5):1458-65. PubMed ID: 12054679
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative effects of hepatocyte growth factor and epidermal growth factor on motility, morphology, mitogenesis, and signal transduction of primary rat hepatocytes.
    Stolz DB; Michalopoulos GK
    J Cell Biochem; 1994 Aug; 55(4):445-64. PubMed ID: 7962176
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impaired liver regeneration in mice lacking methionine adenosyltransferase 1A.
    Chen L; Zeng Y; Yang H; Lee TD; French SW; Corrales FJ; García-Trevijano ER; Avila MA; Mato JM; Lu SC
    FASEB J; 2004 May; 18(7):914-6. PubMed ID: 15033934
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibitory effect of ethanol on hepatocyte growth factor-induced DNA synthesis and Ca2+ mobilization in rat hepatocytes.
    Saso K; Higashi K; Nomura T; Hoshino M; Ito M; Moehren G; Hoek JB
    Alcohol Clin Exp Res; 1996 Dec; 20(9 Suppl):330A-334A. PubMed ID: 8986232
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The hepatocyte growth factor regulates the synthesis of acute-phase proteins in human hepatocytes: divergent effect on interleukin-6-stimulated genes.
    Guillén MI; Gómez-Lechón MJ; Nakamura T; Castell JV
    Hepatology; 1996 Jun; 23(6):1345-52. PubMed ID: 8675150
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of signal transducer and activator transcription factor 3 in rats with acute hepatic failure.
    Kamohara Y; Sugiyama N; Mizuguchi T; Inderbitzin D; Lilja H; Middleton Y; Neuman T; Demetriou AA; Rozga J
    Biochem Biophys Res Commun; 2000 Jun; 273(1):129-35. PubMed ID: 10873574
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Temporal effects of the detoxification enzyme inducer, benzyl isothiocyanate: activation of c-Jun N-terminal kinase prior to the transcription factors AP-1 and NFkappaB.
    Patten EJ; DeLong MJ
    Biochem Biophys Res Commun; 1999 Apr; 257(1):149-55. PubMed ID: 10092525
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vivo response of hepatocytes to growth factors requires an initial priming stimulus.
    Webber EM; Godowski PJ; Fausto N
    Hepatology; 1994 Feb; 19(2):489-97. PubMed ID: 8294105
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Liver regeneration 4: transcriptional control of liver regeneration.
    Taub R
    FASEB J; 1996 Mar; 10(4):413-27. PubMed ID: 8647340
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibitory effect of hepatocyte growth factor against FaO hepatocellular carcinoma cells may be associated with changes of intracellular signalling pathways mediated by protein kinase C.
    Shiota G; Kawasaki H; Nakamura T; Schmidt EV
    Res Commun Mol Pathol Pharmacol; 1994 Sep; 85(3):271-8. PubMed ID: 7827802
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.